Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Matyas

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Journal of Virology|August 21, 2002
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cellsMangala Rao, Mike Bray, Carl R Alving, et al.
Vaccine|August 12, 2014
Adjuvants for vaccines to drugs of abuse and addictionCarl R Alving, Gary R Matyas, Oscar Torres, et al.
Expert Review of Vaccines|April 2, 2020
Army Liposome Formulation (ALF) family of vaccine adjuvantsCarl R Alving, Kristina K Peachman, Gary R Matyas, et al.
Biochemical and Biophysical Research Communications|January 30, 2007
Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphateZoltan Beck, Nicos Karasavvas, James Tong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 13, 2018
Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complexZoltan Beck, Oscar B Torres, Gary R Matyas, et al.
Expert Review of Vaccines|August 10, 2012
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccinesCarl R Alving, Mangala Rao, Nicholas J Steers, et al.
Vaccines|November 26, 2025
Evaluating the Immune Response in Rabbits to an Escalating Dose of mRNA-Based HIV-1 Env ImmunogensShamim Ahmed, Durgadevi Parthasarathy, Tashina C Picard, et al.
Immunology and Cell Biology|October 14, 2004
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope proteinMangala Rao, Gary R Matyas, Thomas C Vancott, et al.
International Journal of Pharmaceutics|June 10, 2019
Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technologyPushpendra Singh, Jeffrey Bodycomb, Bill Travers, et al.
Vaccine|September 16, 2015
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21Zoltan Beck, Gary R Matyas, Rashmi Jalah, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of Virology|August 21, 2002
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cellsMangala Rao, Mike Bray, Carl R Alving, et al.
Vaccine|August 12, 2014
Adjuvants for vaccines to drugs of abuse and addictionCarl R Alving, Gary R Matyas, Oscar Torres, et al.
Expert Review of Vaccines|April 2, 2020
Army Liposome Formulation (ALF) family of vaccine adjuvantsCarl R Alving, Kristina K Peachman, Gary R Matyas, et al.
Biochemical and Biophysical Research Communications|January 30, 2007
Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphateZoltan Beck, Nicos Karasavvas, James Tong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 13, 2018
Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complexZoltan Beck, Oscar B Torres, Gary R Matyas, et al.
Expert Review of Vaccines|August 10, 2012
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccinesCarl R Alving, Mangala Rao, Nicholas J Steers, et al.
Vaccines|November 26, 2025
Evaluating the Immune Response in Rabbits to an Escalating Dose of mRNA-Based HIV-1 Env ImmunogensShamim Ahmed, Durgadevi Parthasarathy, Tashina C Picard, et al.
Immunology and Cell Biology|October 14, 2004
Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope proteinMangala Rao, Gary R Matyas, Thomas C Vancott, et al.
International Journal of Pharmaceutics|June 10, 2019
Particle size analyses of polydisperse liposome formulations with a novel multispectral advanced nanoparticle tracking technologyPushpendra Singh, Jeffrey Bodycomb, Bill Travers, et al.
Vaccine|September 16, 2015
Differential immune responses to HIV-1 envelope protein induced by liposomal adjuvant formulations containing monophosphoryl lipid A with or without QS21Zoltan Beck, Gary R Matyas, Rashmi Jalah, et al.
Pageof 12